All individual trials at Hackensack Meridian Health

8 out of 9

88.9%

$16,659,360

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
reported-late	Hackensack Meridian Health	NCT03896230	Comparison of Ketamine 0.1 mg/kg, 0.2 mg/kg, and 0.3 mg/kg Intravenous Doses for Acute Pain in the Emergency Department: A Prospective, Randomized, Double-blind, Active-controlled, Clinical Trial	2019-12-20	843
reported	Hackensack Meridian Health	NCT04345653	Feasibility, Safety and Early Efficacy Trial of Hydroxychloroquine as Primary Prevention of Corona Virus Disease 2019 in High Risk Health Care Providers	2020-06-05
reported-late	Hackensack Meridian Health	NCT01366612	PRO#1278: A Phase III Study of Fludarabine and Busulfan Versus Fludarabine, Busulfan and Low Dose Total Body Irradiation in Patients Receiving an Allogeneic Hematopoietic Stem Cell Transplant [pACT]	2020-08-17	458
reported-late	Hackensack Meridian Health	NCT04456413	Phase II Randomized Study of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Subjects With Early COVID-19 Infection	2021-04-29	224
reported-late	Hackensack Meridian Health	NCT01723839	Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance [pACT]	2021-06-08	30
reported	Hackensack Meridian Health	NCT03888287	Parkinson's Disease Inpatient Clinical Knowledge and Management	2022-01-03
reported-late	Hackensack Meridian Health	NCT02906332	A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone as Post Autologous Transplant Consolidation in Patients With High-risk Multiple Myeloma [pACT]	2022-05-31	22
overdue	Hackensack Meridian Health	NCT02338232	Pilot Study of Telmisartan (Micardis) For the Prevention of Acute Graft vs. Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation [pACT]	2023-01-05	35
reported	Hackensack Meridian Health	NCT04343755	Phase IIa Study Exploring the Safety and Efficacy of Convalescent Plasma From Recovered COVID-19 Donors Collected by Plasmapheresis as Treatment for Hospitalized Subjects With COVID-19 Infection	2023-04-26
ongoing	Hackensack Meridian Health	NCT01241708	Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma [pACT]	2023-07-15
ongoing	Hackensack Meridian Health	NCT04700176	A Multi-Center Phase 2 Study of Daratumumab With Pomalidomide and Dexamethasone in Combination With All-Transretinoic Acid in Patients With Multiple Myeloma Previously Exposed to Daratumumab-Based Regimens	2023-11-15
ongoing	Hackensack Meridian Health	NCT02681302	Phase Ib-IIA Study of Combined Check Point Inhibition After Autologous Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence [pACT]	2024-02-29
ongoing	Hackensack Meridian Health	NCT01297764	A Phase I/II Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma [pACT]	2024-11-30
ongoing	Hackensack Meridian Health	NCT05776953	Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic	2024-12-20
ongoing	Hackensack Meridian Health	NCT04661137	A Phase 2B Study of Selinexor (KPT-330), in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma Relapsing on Current Therapy	2025-01-31
ongoing	Hackensack Meridian Health	NCT06014242	Peripheral Microvascular Resistance as a Predictor for Limb Salvage in Post-Intervention Critical Limb Ischemia Patients	2025-02-15
ongoing	Hackensack Meridian Health	NCT03609580	Post-operative Urinary Retention (POUR) Following Thoracic Surgery	2025-05-02
ongoing	Hackensack Meridian Health	NCT04263025	Prospective, Controlled Study Evaluating Recovery of Potency and Continence Following Robot-Assisted Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft	2025-10-01
ongoing	Hackensack Meridian Health	NCT05199311	A Phase I/II Study of Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Patients With Newly Diagnosed Transplant Eligible Multiple Myeloma	2025-11-30
ongoing	Hackensack Meridian Health	NCT05715229	A Multicenter Phase II Randomized Trial Of Immunotherapy Versus Chemotherapy Guided By Circulating Tumor DNA-Based Molecular Response On Patients With Metastatic NSCLC	2026-04-28
ongoing	Hackensack Meridian Health	NCT05726383	MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Osteosarcoma After Resection Of Pulmonary Metastases	2027-01-01

Download this data